Anji Pharmaceuticals
Latest round
- Series A
Last raised
- Sep 2020
Total raised
- $26M
Investors
- 1
About Anji Pharmaceuticals
Based in Shanghai, China, and established in 2018, Anji Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the R&D of innovative drugs for metabolic diseases.D. Brian Hubbard, has over 20 years of biopharmaceutical experience at Millennium Pharmaceuticals, Novartis, and Merck. Also, the company has additional offices in the USA. The company developed candidate drugs for chronic kidney disease and chronic constipation. The company's products pipelines include ANJ900 Metformin DR, ANJ908 Pradigastat, ANJ810 MCL1 Inhibitor and ANJ114 HCK Inhibitor. ANJ900 Metformin DR is designed for gut-targeted delivery of metformin and is in Phase 3 clinical trials for Type 2 diabetes (T2D) patients with moderate renal impairment. ANJ908 Pradigastat is in Phase 2 clinical trials to treat chronic idiopathic constipation. The ANJ810 MCL1 Inhibitor can specific killing cancer cells in preclinical models. ANJ114 HCK Inhibitor can treat myeloid leukemia.
Who invested in Anji Pharmaceuticals
1 investor across 2 rounds
See all investors in Anji Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Anji Pharmaceuticals
Who invested in Anji Pharmaceuticals?
Anji Pharmaceuticals has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anji Pharmaceuticals raised?
Anji Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Anji Pharmaceuticals last raise money?
Anji Pharmaceuticals's most recent round on record is a Series A, in Sep 2020.
What does Anji Pharmaceuticals do?
Based in Shanghai, China, and established in 2018, Anji Pharmaceuticals Inc.
Where is Anji Pharmaceuticals headquartered?
Anji Pharmaceuticals is headquartered in Shanghai, China.
Which VCs invest in companies like Anji Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Anji Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Anji Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.